Search
forResearch 10 of 286
- Advances in nucleoside monophosphate prodrugs as anti-HCV agents
- Medications Altering Sex Hormone Balance and Risk of Advanced Liver Disease in HCV-infected Males
- Tu1491 – Use of Androgen Lowering Medications Finasteride and Dutasteride Do Not Substantially Alter Risk of Incident Hcvrelated Hepatcellular Carcinoma in Men
- Dermatological Manifestations of Pegylated Interferon alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients
- Lichenoid dermatitis from interferon alpha-2a in a patient with metastatic renal cell carcinoma and seronegative HCV
- Cutaneous and Mucosal Lichen Planus: A Comprehensive Review of Clinical Subtypes, Risk Factors, Diagnosis, and Prognosis
- Reversible alopecia universalis secondary to PEG-interferon ??-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection
- Familial and Sporadic Porphyria Cutanea Tarda
- High dose interferon treatment in chronic hepatitis C.
- Lichen planus and other cutaneous manifestations in chronic hepatitis C: pre- and post-interferon-based treatment prevalence vary in a cohort of patients from low hepatitis C virus endemic area
Learn
— no results
Try a deeper search in learn →Community
— no results
Try a deeper search in community →